More strikingly, through expression modulation and activity inhibition, we have unveiled that TPCI-induced ferroptosis does not require the participation of ACSL4, and can be occurred on a variety of cancer cells with different ACSL4 expression levels. The gene discussed is ACSL4; the disease is cancer.